TY - JOUR
T1 - Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women
AU - Gunter, Marc J.
AU - Hoover, Donald R.
AU - Yu, Herbert
AU - Wassertheil-Smoller, Sylvia
AU - Rohan, Thomas E.
AU - Manson, Joann E.
AU - Howard, Barbara V.
AU - Wylie-Rosett, Judith
AU - Anderson, Garnet L.
AU - Ho, Gloria Y.F.
AU - Kaplan, Robert C.
AU - Li, Jixin
AU - Xue, Xiaonan
AU - Harris, Tiffany G.
AU - Burk, Robert D.
AU - Strickler, Howard D.
PY - 2008/1/1
Y1 - 2008/1/1
N2 - Obesity is a risk factor for colorectal cancer, and hyperinsulinemia, a common condition in obese patients, may underlie this relationship. Insulin, in addition to its metabolic effects, has promitotic and antiapoptotic activity that may be tumorigenic. Insulin-like growth factor (IGF)-I, a related hormone, shares sequence homology with insulin, and has even stronger mitogenic effects. However, few prospective colorectal cancer studies directly measured fasting insulin, and none evaluated free IGF-I, or endogenous estradiol, a potential cofactor in postmenopausal women. Therefore, we conducted a case-cohort investigation of colorectal cancer among nondiabetic subjects enrolled in the Women's Health Initiative Observational Study, a prospective cohort of 93,676 postmenopausal women. Fasting baseline serum specimens from all incident colorectal cancer cases (n = 438) and a random subcohort (n = 816) of Women's Health Initiative Observational Study subjects were tested for insulin, glucose, total IGF-I, free IGF-I, IGF binding protein-3, and estradiol. Comparing extreme quartiles, insulin [hazard ratio (HR)q4-q1, 1.73; 95% confidence interval (CI), 1.16-2.57; Ptrend = 0.005], waist circumference (HRq4-q1, 1.82; 95% CI, 1.22-2.70; Ptrend = 0.001), and free IGF-I (HRq4-q1, 1.35; 95% CI, 0.92-1.98; P trend = 0.05) were each associated with colorectal cancer incidence in multivariate models. However, these associations each became nonsignificant when adjusted for one another. Endogenous estradiol levels, in contrast, were positively associated with risk of colorectal cancer (HR comparing high versus low levels, 1.53; 95% CI, 1.05-2.22), even after control for insulin, free IGF-I, and waist circumference. These data suggest the existence of at least two independent biological pathways that are related to colorectal cancer: one that involves endogenous estradiol, and a second pathway broadly associated with obesity, hyperinsulinemia, and free IGF-I.
AB - Obesity is a risk factor for colorectal cancer, and hyperinsulinemia, a common condition in obese patients, may underlie this relationship. Insulin, in addition to its metabolic effects, has promitotic and antiapoptotic activity that may be tumorigenic. Insulin-like growth factor (IGF)-I, a related hormone, shares sequence homology with insulin, and has even stronger mitogenic effects. However, few prospective colorectal cancer studies directly measured fasting insulin, and none evaluated free IGF-I, or endogenous estradiol, a potential cofactor in postmenopausal women. Therefore, we conducted a case-cohort investigation of colorectal cancer among nondiabetic subjects enrolled in the Women's Health Initiative Observational Study, a prospective cohort of 93,676 postmenopausal women. Fasting baseline serum specimens from all incident colorectal cancer cases (n = 438) and a random subcohort (n = 816) of Women's Health Initiative Observational Study subjects were tested for insulin, glucose, total IGF-I, free IGF-I, IGF binding protein-3, and estradiol. Comparing extreme quartiles, insulin [hazard ratio (HR)q4-q1, 1.73; 95% confidence interval (CI), 1.16-2.57; Ptrend = 0.005], waist circumference (HRq4-q1, 1.82; 95% CI, 1.22-2.70; Ptrend = 0.001), and free IGF-I (HRq4-q1, 1.35; 95% CI, 0.92-1.98; P trend = 0.05) were each associated with colorectal cancer incidence in multivariate models. However, these associations each became nonsignificant when adjusted for one another. Endogenous estradiol levels, in contrast, were positively associated with risk of colorectal cancer (HR comparing high versus low levels, 1.53; 95% CI, 1.05-2.22), even after control for insulin, free IGF-I, and waist circumference. These data suggest the existence of at least two independent biological pathways that are related to colorectal cancer: one that involves endogenous estradiol, and a second pathway broadly associated with obesity, hyperinsulinemia, and free IGF-I.
UR - http://www.scopus.com/inward/record.url?scp=39149111599&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=39149111599&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-07-2946
DO - 10.1158/0008-5472.CAN-07-2946
M3 - Article
C2 - 18172327
AN - SCOPUS:39149111599
SN - 0008-5472
VL - 68
SP - 329
EP - 337
JO - Cancer Research
JF - Cancer Research
IS - 1
ER -
